Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) saw a large drop in short interest in July. As of July 15th, there was short interest totaling 37 shares, a drop of 96.4% from the June 30th total of 1,033 shares. Based on an average daily trading volume, of 7,749 shares, the short-interest ratio is presently 0.0 days.
Carl Zeiss Meditec Price Performance
OTCMKTS:CZMWY traded up $0.33 during trading hours on Friday, reaching $31.40. The company’s stock had a trading volume of 650 shares, compared to its average volume of 4,705. The firm has a 50-day simple moving average of $31.02 and a 200-day simple moving average of $32.20. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $60.10.
Analysts Set New Price Targets
Separately, Zacks Research raised Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. One analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold”.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
